Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CDER’s Counter-Terrorism, Emergency Coordination Operations Get New Home

This article was originally published in The Pink Sheet Daily

Executive Summary

Staff involved in medical countermeasure drug development and coordination of emergency activities will move into CDER director’s office, which also now houses the drug shortages program.


Related Content

FDA Safety Meetings: Outpatient Drugs, Hypoglycemia Getting Limelight
CDER Outreach Coordinator’s First Task Is Safe Use Initiative
Pharmaceutical Quality And Generic Drugs: Janet Woodcock Explains Her Vision
FDA Drug Shortage Staff Gets Higher Profile As New Reporting Requirements Begin
Generic Drugs Gain Status Boost Within CDER





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts